SCHEMBL19946360

SCHEMBL19946360

CCCCCCCCCC(O)=CO

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 7/20 0.50
PPARG P37231 7/20 0.50
PPARD Q03181 7/20 0.50
PPARA Q07869 7/20 0.50
HDAC11 Q96DB2 5/20 0.50
TSHR P16473 4/20 0.50
PTPN1 P18031 3/20 0.50
FABP4 P15090 3/20 0.50
ALDH1A1 P00352 2/20 0.50
TLR2 O60603 2/20 0.50
TDP1 Q9NUW8 2/20 0.50
ALOX15 P16050 2/20 0.50
HSD17B10 Q99714 2/20 0.50
SLC22A6 Q4U2R8 1/20 0.50
SLC22A8 Q8TCC7 1/20 0.50
MEN1 O00255 1/20 0.50
ESR1 P03372 1/20 0.50
PDE4A P27815 1/20 0.50
KMT2A Q03164 1/20 0.50
PDE3A Q14432 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4597396 1.00 GPR84 (0.50) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL15253969 1.00 GPR84 (0.50) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL30897212 1.00 GPR84 (0.50) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL6678271 1.00 GPR84 (0.50) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL19946361 1.00 GPR84 (0.50) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL5367892 1.00 GPR84 (0.50) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL6678274 1.00 GPR84 (0.50) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL5367890 1.00 GPR84 (0.50) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL4597394 1.00 GPR84 (0.50) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL3122384 0.97

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4706780-A2 COMPOSITIONS COMPRISING UV-FILTERS AND ONE OR MORE (BIO)-ALKANEDIOLS Symrise AG (DE) 2026-03-11 EP disclosed
EP-4110276-B1 COMPOSITIONS COMPRISING ALKANEDIOLS SYMRISE AG (DE) 2026-01-28 EP disclosed
EP-4616840-A2 COMPOSITIONS COMPRISING (BIO)-ALKANEDIOLS WITH ANTIMICROBIALS FOR PRODUCT PROTECTION Symrise AG (DE) 2025-09-17 EP disclosed
US-20250255833-A1 Compositions Comprising One or More (Bio)-Alkanediols with Antioxidants SYMRISE AG (DE) 2025-08-14 US disclosed
EP-4582079-A2 COMPOSITIONS COMPRISING (BIO)-ALKANEDIOLS WITH ANTIMICROBIALS FOR PRODUCT PROTECTION Symrise AG (DE) 2025-07-09 EP disclosed
US-12303468-B2 Compositions comprising one or more (bio)-alkanediols with antioxidants SYMRISE AG (DE) 2025-05-20 US disclosed
EP-4545065-A2 COMPOSITIONS COMPRISING ONE OR MORE (BIO)-ALKANEDIOLS WITH ANTIOXIDANTS Symrise AG (DE) 2025-04-30 EP disclosed
EP-4110477-B1 COMPOSITIONS COMPRISING ONE OR MORE (BIO)-ALKANEDIOLS WITH ANTIOXIDANTS SYMRISE AG (DE) 2025-03-19 EP disclosed
EP-4477264-A2 COMPOSITIONS COMPRISING ONE OR MORE (BIO)-ALKANEDIOLS WITH ACTIVE INGREDIENTS Symrise AG (DE) 2024-12-18 EP disclosed
EP-4397298-A2 COMPOSITIONS COMPRISING ANTIMICROBIALS AND (BIO)-ALKANEDIOLS FOR SKIN PROTECTION Symrise AG (DE) 2024-07-10 EP disclosed
WO-2022122898-A1 COMPOSITIONS COMPRISING ANTIMICROBIALS AND (BIO)-ALKANEDIOLS FOR SKIN PROTECTION SYMRISE AG (DE) 2022-06-16 WO disclosed
WO-2022122885-A1 COMPOSITIONS COMPRISING LIPOPHILIC COMPOUNDS AND ONE OR MORE (BIO)-ALKANEDIOLS SYMRISE AG (DE) 2022-06-16 WO disclosed
WO-2022122896-A1 COMPOSITIONS COMPRISING ONE OR MORE (BIO)-ALKANEDIOLS WITH ANTIOXIDANTS SYMRISE AG (DE) 2022-06-16 WO disclosed
WO-2022122935-A1 COMPOSITIONS COMPRISING ONE OR MORE (BIO)-ALKANEDIOLS WITH ACTIVE INGREDIENTS SYMRISE AG (DE) 2022-06-16 WO disclosed
WO-2022122894-A1 COMPOSITIONS COMPRISING UV-FILTERS AND ONE OR MORE (BIO)-ALKANEDIOLS SYMRISE AG (DE) 2022-06-16 WO disclosed
WO-2022122930-A1 COMPOSITIONS COMPRISING (BIO)-ALKANEDIOLS WITH ANTIMICROBIALS FOR PRODUCT PROTECTION SYMRISE AG (DE) 2022-06-16 WO disclosed
US-20210121424-A1 ANTIMICROBIAL COMPOSITION ROTTAPHARM SPA (IT) 2021-04-29 US disclosed
US-10912747-B2 Antimicrobial composition ROTTAPHARM SPA 2021-02-09 US disclosed
US-20190247341-A1 ANTIMICROBIAL COMPOSITION ROTTAPHARM SPA (IT) 2019-08-15 US disclosed
EP-3292758-A1 ANTIMICROBIAL COMPOSITION COMPRISING A CARBOXYLIC ACID AND TWO DIOLS Rottapharm S.p.A. (IT) 2018-03-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250255833-A1 Compositions Comprising One or More (Bio)-Alkanediols with Antioxidants MMP8, CXCL8, IL18 GPR84 2294/4885PPARG 582/4885PPARD 632/4885
US-12303468-B2 Compositions comprising one or more (bio)-alkanediols with antioxidants MMP8, CXCL8, IL18 GPR84 2294/4885PPARG 582/4885PPARD 632/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.